959
Participants
Start Date
May 25, 2017
Primary Completion Date
November 1, 2023
Study Completion Date
November 1, 2023
670G and 770G Insulin Pump
Medtronic 670G and 770G Hybrid Closed Loop Systems
Subject's Current Diabetes Therapy
Subject will use current diabetes therapy: CSII (Continuous Subcutaneous Insulin Infusion), MDI (Multiple Daily Injections) or SAP (Sensor Augmented Pump).
New Zealand Clinical Research, Christchurch
Dunedin Public Hospital, Dunedin
SUNY Upstate Medical University, Syracuse
A.S.S.T. Spedali Civili, Brescia
Endocrine Research Solutions, Roswell
Diabeteszentrum für Kinder und Jugendliche, Kinder- und Jugendkrankenhaus Auf der Bult, Hanover
Atlanta Diabetes Associates, Atlanta
University of South Florida Diabetes Center, Tampa
Indiana University Health Riley Hospital for Children, Indianapolis
University of Michigan, Ann Arbor
Grunberger Diabetes Institute, Bloomfield Hills
IDERC, Des Moines
Initernational Diabetes Center, Minneapolis
International Diabetes Center, Minneapolis
Mayo Clinic, Rochester
Sanford Health, Sioux Falls
Washington University St. Louis, St Louis
HCL - Lyon Sud, Pierre-Bénite
Hôpital Necker Enfants Malades, Paris
Diabetes and Glandular Disease Clinic, P.A., San Antonio
Texas Diabetes & Endocrinology, Austin
Barbara Davis Center, Aurora
SoCal Diabetes, Torrance
Scripps Health System, La Jolla
Sansum Diabetes Research Institute, Santa Barbara
Rocky Mountain Diabetes, Idaho Falls
Stanford University, Palo Alto
Diablo Clinical Research, Walnut Creek
Center of Excellence in Diabetes & Endocrinology, Sacramento
Rainier Clinical Research, Renton
University of Washington, Seattle
Westminster Endocrine & Diabetes Research Society, New Westminster
Children's Hospital of Eastern Ontario, Ottawa
Hospital Universitario Virgen del Rocío, Seville
Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital, Cambridge
Dept Internal Medicine, Örebro University Hospital, Örebro
Medtronic Diabetes
INDUSTRY